New Talking Tox Webinars in January!
New Talking Tox Webinars will be held this month with the opportunity for live Q&A
with the presenters. Hosted by ACT Exhibitors and Annual Meeting Supporters, these informative,
commercially supported, educational presentations highlighting case studies and relevant
toxicology research will also be available on demand through February 15, 2022.
Log in to the virtual ACT Annual Meeting platform to participate.
Tuesday, January 11, 2022
12:00 Noon–1:00 PM (EST)
Practical Considerations for a Cell Therapy Preclinical Program
Presented by: Lovelace Biomedical
The use of cell therapies has emerged as a powerful therapeutic approach with the potential to treat and even cure numerous diseases. This webinar will cover development of a successful preclinical safety program to support entry of a cell therapy into the clinic. This process requires a nimble approach where “one size” does not fit all and should be purpose-fit to the specific cell therapy approach.
Thursday, January 20, 2022
12:00 Noon–1:00 PM (EST)
Best Practices for the Conduct of Preclinical Ototoxicity Evaluations
Presented by: CBSET
Ototoxicity resulting in inner ear damage is a common form of hearing loss. Current guidance for human drug development does not request auditory assessment, which has resulted in more than 200 ototoxic marketed medications. This webinar will provide a look into ototoxicity evaluation from screening to GLP studies with FDA guidelines.
ACT Exhibitors and Supporters hosted 15 Talking Tox Webinars during the virtual 42nd Annual Meeting in November. Those recordings are also available on demand through February 15, 2022.
Log in to the ACT Annual Meeting platform to view these recordings.Monday, November 8, 2021
Case Studies: Adversity Level Determination in Nonclinical Toxicity Studies—A CRO Perspective
Presented by: Altasciences
Elevate Your Toxicity Assays: New Models with Biological Relevance and Predictability
Presented by: ATCC
Direct CNS Delivery of Oligonucleotides: Beware of the Unexpected
Presented by: Charles River
The Use of Minipigs in Juvenile Studies
Presented by: Marshall BioResources
Tuesday, November 9, 2021
Pharmaceutical Environmental Risk Assessment: Planning for Submission to the US FDA
and EU EMA
Presented by: Eurofins Regulatory Science Services
Today’s SEND Challenges: How to Overcome Them and Realize Tomorrow’s R&D Opportunities
Presented by: Instem
Applications of Immune Cells and Cardiomyocytes in Drug Discovery
Presented by: Stemcell Technologies, Inc.
Trends for Nonhuman Primate (NHP) Use in Drug Development: Origins, Supplies, Alternatives,
and the 3Rs
Presented by: WuXi AppTec
Thursday, November 11, 2021
Reducing the Risk of Neurotoxicity—Trends and Future Outlook
Presented by: Cyprotex
Target Safety Assessments: How Augmented Intelligence Is Advancing Insights for Quicker, Evidence-Based Decision-Making
Presented by: Instem
Computational Approaches for Assessing Carcinogenic Potency of Nitrosamines
Presented by: MultiCASE
Choosing the Right Model: Miniature Swine Model Selection Criteria for Toxicology and Pharmacology Studies
Presented by: Sinclair Research
Development of N-Nitrosamine Potency Classes to Support Regulatory Submissions
Presented by: Instem
Safety of E-cig Products—A Toxicological Challenge
Presented by: Product Safety Labs
Novel Approach Methods in Genotoxicity and Developmental Toxicity Assessment
Presented by: ToxysInterested in hosting a Talking Tox Webinar? Please contact Liz Kasabian, exhibits@actox.org.
|